TG Therapeutics, Inc. (TGTX)
54.17
+1.01
(+1.90%)
USD |
NASDAQ |
Oct 23, 16:00
54.35
+0.18
(+0.33%)
Pre-Market: 20:00
TG Therapeutics 1 Year Total Returns (Daily) : 61.75% for Oct. 23, 2026
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| October 23, 2026 | 61.75% |
| October 22, 2026 | 53.69% |
| October 21, 2026 | 51.05% |
| October 20, 2026 | 55.27% |
| October 19, 2026 | 53.74% |
| October 16, 2026 | 54.77% |
| October 15, 2026 | 59.77% |
| October 14, 2026 | 59.26% |
| October 13, 2026 | 58.80% |
| October 12, 2026 | 63.71% |
| October 09, 2026 | 58.34% |
| October 08, 2026 | 49.20% |
| October 07, 2026 | 45.07% |
| October 06, 2026 | 41.98% |
| October 05, 2026 | 46.87% |
| October 02, 2026 | 48.09% |
| October 01, 2026 | 46.66% |
| September 30, 2026 | 54.41% |
| September 29, 2026 | 52.57% |
| September 28, 2026 | 58.28% |
| September 25, 2026 | 65.79% |
| September 24, 2026 | 62.44% |
| September 23, 2026 | 57.44% |
| September 22, 2026 | 66.17% |
| September 21, 2026 | 76.58% |
| Date | Value |
|---|---|
| September 18, 2026 | 74.39% |
| September 17, 2026 | 76.25% |
| September 16, 2026 | 74.59% |
| September 15, 2026 | 67.06% |
| September 14, 2026 | 67.91% |
| September 11, 2026 | 66.02% |
| September 10, 2026 | 74.05% |
| September 09, 2026 | 70.78% |
| September 08, 2026 | 72.14% |
| September 04, 2026 | 75.56% |
| September 03, 2026 | 78.84% |
| September 02, 2026 | 91.39% |
| September 01, 2026 | 91.24% |
| August 31, 2026 | 85.13% |
| August 28, 2026 | 86.22% |
| August 27, 2026 | 95.03% |
| August 26, 2026 | 94.59% |
| August 25, 2026 | 94.25% |
| August 24, 2026 | 90.22% |
| August 21, 2026 | 88.63% |
| August 20, 2026 | 78.59% |
| August 19, 2026 | 85.14% |
| August 18, 2026 | 81.25% |
| August 17, 2026 | 75.50% |
| August 14, 2026 | 75.51% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Krystal Biotech, Inc. | 67.07% |
| Vertex Pharmaceuticals, Inc. | 23.97% |
| SELLAS Life Sciences Group, Inc. | 504.2% |
| Travere Therapeutics, Inc. | 77.90% |
| Alnylam Pharmaceuticals, Inc. | -51.72% |